GNPAT anticorps (AA 201-300)

N° du produit ABIN709106

L’anticorps Lapin Polyclonal anti-GNPAT a été validé pour ELISA, WB, IHC (p), IF (cc), IF (p) et IHC (fro). Il convient pour détecter GNPAT dans des échantillons de Humain.

Aperçu rapide pour GNPAT anticorps (AA 201-300) (ABIN709106)

Antigène: GNPAT (Glyceronephosphate O-Acyltransferase (GNPAT))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp GNPAT est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-GNPAT anticorps

Épitope: AA 201-300

Réactivité croisée: Humain

Homologie: Mouse,Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human GNPAT

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur GNPAT

Antigène: GNPAT (Glyceronephosphate O-Acyltransferase (GNPAT))

Autre désignation: GNPAT

Sujet:

Synonyms: DAPAT, DAP-AT, DHAPAT, Dihydroxyacetone phosphate acyltransferase, DHAP-AT, Acyl-CoA:dihydroxyacetonephosphateacyltransferase, Glycerone-phosphate O-acyltransferase, GNPAT

Background: GNPAT is a key enzyme located in the peroxisomal membrane which is essential to the synthesis of ether phospholipids. Mutations in GNPAT are associated with rhizomelic chondrodysplasia punctata type 2, which is characterized by rhizomelic shortening of femur and humerus, vertebral disorders, cataract, cutaneous lesions and severe mental retardation.

ID gène: 8443

UniProt: O15228

Pathways: Cell-Cell Junction Organization